Reldesemtiv
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Reldesemtiv, covering 2024-12-05 to 2024-12-05. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Reldesemtiv in Patients With Amyotrophic Lateral Sclerosis (ALS) [Phase 3]